Pirnabin
Prijeđi na navigaciju
Prijeđi na pretragu
![]() | |||
(IUPAC) ime | |||
---|---|---|---|
(3,6,6,9-tetrametil-7,8,9,10-tetrahidrobenzo[c]hromen-1-il) acetat | |||
Klinički podaci | |||
Identifikatori | |||
CAS broj | 68298-00-0 | ||
ATC kod | nije dodeljen | ||
PubChem[1][2] | 50137 | ||
UNII | S3FHL03F60 ![]() | ||
Hemijski podaci | |||
Formula | C19H24O3 | ||
Mol. masa | 300,391 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
Pirnabin (SP-304) je sinthetički ligand kanabinoidnog receptora. Ovo jedinjenje je razvijeno za tretman glaukoma.[3]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Stig Agurell, ur. The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects. ISBN 9780323141987.
- Stig Agurell, ur. The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects. ISBN 9780323141987.